PharmacyCodes



Cefmenoxima [INN-Spanish] en es it fr

Cefmenoxima [INN-Spanish] Brand names, Cefmenoxima [INN-Spanish] Analogs

Cefmenoxima [INN-Spanish] Brand Names Mixture

  • No information avaliable

Cefmenoxima [INN-Spanish] Chemical_Formula

C16H17N9O5S3

Cefmenoxima [INN-Spanish] RX_link

No information avaliable

Cefmenoxima [INN-Spanish] fda sheet

Cefmenoxima [INN-Spanish] msds (material safety sheet)

Cefmenoxima [INN-Spanish] Synthesis Reference

No information avaliable

Cefmenoxima [INN-Spanish] Molecular Weight

511.562 g/mol

Cefmenoxima [INN-Spanish] Melting Point

No information avaliable

Cefmenoxima [INN-Spanish] H2O Solubility

No information avaliable

Cefmenoxima [INN-Spanish] State

Solid

Cefmenoxima [INN-Spanish] LogP

-1.056

Cefmenoxima [INN-Spanish] Dosage Forms

Solution for injection

Cefmenoxima [INN-Spanish] Indication

Used to treat female gynecologic and obstetric infections caused by susceptible aerobic (including the gonococcus) and anaerobic bacteria.

Cefmenoxima [INN-Spanish] Pharmacology

Cefmenoxime is a semisynthetic beta-lactam cephalosporin antibiotic with activity similar to that of cefotaxime. It has broad spectrum activity against Gram positive and Gram negative bacteria.

Cefmenoxima [INN-Spanish] Absorption

Bioavailability is approximately 100% following intramuscular injection.

Cefmenoxima [INN-Spanish] side effects and Toxicity

Information on cefmenoxime overdosage in humans is not available. However, with other b-lactam antibiotics, adverse effects following overdosage have included nausea, vomiting, epigastric distress, diarrhea, and convulsions.

Cefmenoxima [INN-Spanish] Patient Information

No information avaliable

Cefmenoxima [INN-Spanish] Organisms Affected

Enteric bacteria and other eubacteria